Factors related with treatment adherence to interferon b and glatiramer acetate therapy in multiple sclerosis
Jordi Río(Universitat Autònoma de Barcelona), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Mar Tintoré(Vall d'Hebron Hospital Universitari), Angela Sánchez-Betancourt(Vall d'Hebron Hospital Universitari), María Jesús Arévalo(Universitat Autònoma de Barcelona), J. Porcel(Vall d'Hebron Hospital Universitari), Nieves Téllez(Vall d'Hebron Hospital Universitari), Carlos Nos(Universitat Autònoma de Barcelona)
Cited by 188
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k